Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
245 hedge funds and large institutions have $3.66B invested in Cantel Medical Corporation in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 82 increasing their positions, 86 reducing their positions, and 22 closing their positions.
221% more call options, than puts
Call options by funds: $5.35M | Put options by funds: $1.67M
68% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 22
7% more capital invested
Capital invested by funds: $3.42B → $3.66B (+$239M)
6% more funds holding
Funds holding: 231 → 245 (+14)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
5% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 86
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$63.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$20.7M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$19.6M |
| 4 |
Neuberger Berman Group
New York
|
+$13.6M |
| 5 |
Morgan Stanley
New York
|
+$8.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$40.7M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$25M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$24.8M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$22.9M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$19.4M |
CMD Hedge Fund Activity: Q4 2017 in Review
245 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2017, worth a combined $3.66B — up 7% from $3.42B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CMD positions and 22 closed out — a net gain of 15 holders — while 82 added to existing stakes and 86 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $63.7M. The largest seller was Nationwide Fund Advisors, exiting entirely with an estimated $40.7M sold.
- 245 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2017, up from 231 in Q3 2017.
- Funds reported $3.66B of Cantel Medical Corporation stock for Q4 2017, up 7% quarter-over-quarter.
- 37 funds opened new Cantel Medical Corporation positions in Q4 2017 and 22 closed out, a net change of +15 holders.
- The largest Cantel Medical Corporation buyer in Q4 2017 was Wasatch Advisors, an estimated $63.7M added.
- The largest Cantel Medical Corporation seller in Q4 2017 was Nationwide Fund Advisors, an estimated $40.7M sold.
Based on aggregated 13F filings for Q4 2017.